Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci

Shih Ming Tsao, Hsiu Chen Lin, Chun Ming Lee, Gwo Jong Hsu, Chih Ming Chen, Wu Sun, Yung Ching Liu, Tsrang Neng Jang, Yu Jen Cheng, Po Liang Lu, Ping Chreng Chiang, Lih Shinn Wang, Hsiang Chi Kung, Yin Ching Chuang, Zhi Yuan Shi, Jien Wei Liu, Cheng Hua Huang, Chin Te Lu, Chun Hsing Liao, Po Ren Hsueh

研究成果: 雜誌貢獻文章

6 引文 (Scopus)

摘要

Tigecycline In-vitro Surveillance in Taiwan (TIST), initiated in 2006, is a nationwide surveillance programme designed to monitor longitudinally the in-vitro activity of tigecycline against commonly encountered resistant bacteria in Taiwan. This study, part of TIST-2006 study, aimed to compare the in-vitro activity of tigecycline against clinical isolates of Gram-positive bacteria. A total of 805 isolates of Gram-positive bacteria were collected from patients treated at 20 teaching hospitals. Minimum inhibitory concentrations (MICs) of tigecycline for these isolates were determined by the broth microdilution method according to the guidelines of the Clinical and Laboratory Standards Institute, and by the Etest as per the manufacturer's instructions. Susceptibility results were interpreted by the MIC criteria recommended by the US FDA. Agreement between the two methods was low: 80.7% for methicillin-resistant Staphylococcus aureus (MRSA), 27.2% for Streptococcus pneumoniae, 22.8% for other Streptococcus spp., and 30.8% for vancomycin-resistant E. faecium (VRE). There were no very major or major errors noted. Tigecycline exhibited excellent in-vitro activity against Gram-positive cocci, including MRSA, VRE, S. pneumoniae and other Streptococcus spp. isolates in Taiwan. Correlation between MIC values determined using the broth microdilution and Etest methods for these organisms was poor.

原文英語
期刊International Journal of Antimicrobial Agents
32
發行號SUPPL. 3
DOIs
出版狀態已發佈 - 十一月 2008
對外發佈Yes

指紋

Gram-Positive Cocci
Taiwan
Microbial Sensitivity Tests
Disk Diffusion Antimicrobial Tests
Gram-Positive Bacteria
Vancomycin
Methicillin-Resistant Staphylococcus aureus
Streptococcus pneumoniae
Streptococcus
Teaching Hospitals
tigecycline
In Vitro Techniques
Guidelines
Bacteria

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)

引用此文

Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci. / Tsao, Shih Ming; Lin, Hsiu Chen; Lee, Chun Ming; Hsu, Gwo Jong; Chen, Chih Ming; Sun, Wu; Liu, Yung Ching; Jang, Tsrang Neng; Cheng, Yu Jen; Lu, Po Liang; Chiang, Ping Chreng; Wang, Lih Shinn; Kung, Hsiang Chi; Chuang, Yin Ching; Shi, Zhi Yuan; Liu, Jien Wei; Huang, Cheng Hua; Lu, Chin Te; Liao, Chun Hsing; Hsueh, Po Ren.

於: International Journal of Antimicrobial Agents, 卷 32, 編號 SUPPL. 3, 11.2008.

研究成果: 雜誌貢獻文章

Tsao, SM, Lin, HC, Lee, CM, Hsu, GJ, Chen, CM, Sun, W, Liu, YC, Jang, TN, Cheng, YJ, Lu, PL, Chiang, PC, Wang, LS, Kung, HC, Chuang, YC, Shi, ZY, Liu, JW, Huang, CH, Lu, CT, Liao, CH & Hsueh, PR 2008, 'Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci', International Journal of Antimicrobial Agents, 卷 32, 編號 SUPPL. 3. https://doi.org/10.1016/S0924-8579(08)70025-6
Tsao, Shih Ming ; Lin, Hsiu Chen ; Lee, Chun Ming ; Hsu, Gwo Jong ; Chen, Chih Ming ; Sun, Wu ; Liu, Yung Ching ; Jang, Tsrang Neng ; Cheng, Yu Jen ; Lu, Po Liang ; Chiang, Ping Chreng ; Wang, Lih Shinn ; Kung, Hsiang Chi ; Chuang, Yin Ching ; Shi, Zhi Yuan ; Liu, Jien Wei ; Huang, Cheng Hua ; Lu, Chin Te ; Liao, Chun Hsing ; Hsueh, Po Ren. / Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci. 於: International Journal of Antimicrobial Agents. 2008 ; 卷 32, 編號 SUPPL. 3.
@article{5c3319f554c5405592f4c8c15cfb95a7,
title = "Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci",
abstract = "Tigecycline In-vitro Surveillance in Taiwan (TIST), initiated in 2006, is a nationwide surveillance programme designed to monitor longitudinally the in-vitro activity of tigecycline against commonly encountered resistant bacteria in Taiwan. This study, part of TIST-2006 study, aimed to compare the in-vitro activity of tigecycline against clinical isolates of Gram-positive bacteria. A total of 805 isolates of Gram-positive bacteria were collected from patients treated at 20 teaching hospitals. Minimum inhibitory concentrations (MICs) of tigecycline for these isolates were determined by the broth microdilution method according to the guidelines of the Clinical and Laboratory Standards Institute, and by the Etest as per the manufacturer's instructions. Susceptibility results were interpreted by the MIC criteria recommended by the US FDA. Agreement between the two methods was low: 80.7{\%} for methicillin-resistant Staphylococcus aureus (MRSA), 27.2{\%} for Streptococcus pneumoniae, 22.8{\%} for other Streptococcus spp., and 30.8{\%} for vancomycin-resistant E. faecium (VRE). There were no very major or major errors noted. Tigecycline exhibited excellent in-vitro activity against Gram-positive cocci, including MRSA, VRE, S. pneumoniae and other Streptococcus spp. isolates in Taiwan. Correlation between MIC values determined using the broth microdilution and Etest methods for these organisms was poor.",
keywords = "Broth microdilution, Etest, Gram-positive cocci, Taiwan, Tigecycline",
author = "Tsao, {Shih Ming} and Lin, {Hsiu Chen} and Lee, {Chun Ming} and Hsu, {Gwo Jong} and Chen, {Chih Ming} and Wu Sun and Liu, {Yung Ching} and Jang, {Tsrang Neng} and Cheng, {Yu Jen} and Lu, {Po Liang} and Chiang, {Ping Chreng} and Wang, {Lih Shinn} and Kung, {Hsiang Chi} and Chuang, {Yin Ching} and Shi, {Zhi Yuan} and Liu, {Jien Wei} and Huang, {Cheng Hua} and Lu, {Chin Te} and Liao, {Chun Hsing} and Hsueh, {Po Ren}",
year = "2008",
month = "11",
doi = "10.1016/S0924-8579(08)70025-6",
language = "English",
volume = "32",
journal = "International Journal of Antimicrobial Agents",
issn = "0924-8579",
publisher = "Elsevier",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci

AU - Tsao, Shih Ming

AU - Lin, Hsiu Chen

AU - Lee, Chun Ming

AU - Hsu, Gwo Jong

AU - Chen, Chih Ming

AU - Sun, Wu

AU - Liu, Yung Ching

AU - Jang, Tsrang Neng

AU - Cheng, Yu Jen

AU - Lu, Po Liang

AU - Chiang, Ping Chreng

AU - Wang, Lih Shinn

AU - Kung, Hsiang Chi

AU - Chuang, Yin Ching

AU - Shi, Zhi Yuan

AU - Liu, Jien Wei

AU - Huang, Cheng Hua

AU - Lu, Chin Te

AU - Liao, Chun Hsing

AU - Hsueh, Po Ren

PY - 2008/11

Y1 - 2008/11

N2 - Tigecycline In-vitro Surveillance in Taiwan (TIST), initiated in 2006, is a nationwide surveillance programme designed to monitor longitudinally the in-vitro activity of tigecycline against commonly encountered resistant bacteria in Taiwan. This study, part of TIST-2006 study, aimed to compare the in-vitro activity of tigecycline against clinical isolates of Gram-positive bacteria. A total of 805 isolates of Gram-positive bacteria were collected from patients treated at 20 teaching hospitals. Minimum inhibitory concentrations (MICs) of tigecycline for these isolates were determined by the broth microdilution method according to the guidelines of the Clinical and Laboratory Standards Institute, and by the Etest as per the manufacturer's instructions. Susceptibility results were interpreted by the MIC criteria recommended by the US FDA. Agreement between the two methods was low: 80.7% for methicillin-resistant Staphylococcus aureus (MRSA), 27.2% for Streptococcus pneumoniae, 22.8% for other Streptococcus spp., and 30.8% for vancomycin-resistant E. faecium (VRE). There were no very major or major errors noted. Tigecycline exhibited excellent in-vitro activity against Gram-positive cocci, including MRSA, VRE, S. pneumoniae and other Streptococcus spp. isolates in Taiwan. Correlation between MIC values determined using the broth microdilution and Etest methods for these organisms was poor.

AB - Tigecycline In-vitro Surveillance in Taiwan (TIST), initiated in 2006, is a nationwide surveillance programme designed to monitor longitudinally the in-vitro activity of tigecycline against commonly encountered resistant bacteria in Taiwan. This study, part of TIST-2006 study, aimed to compare the in-vitro activity of tigecycline against clinical isolates of Gram-positive bacteria. A total of 805 isolates of Gram-positive bacteria were collected from patients treated at 20 teaching hospitals. Minimum inhibitory concentrations (MICs) of tigecycline for these isolates were determined by the broth microdilution method according to the guidelines of the Clinical and Laboratory Standards Institute, and by the Etest as per the manufacturer's instructions. Susceptibility results were interpreted by the MIC criteria recommended by the US FDA. Agreement between the two methods was low: 80.7% for methicillin-resistant Staphylococcus aureus (MRSA), 27.2% for Streptococcus pneumoniae, 22.8% for other Streptococcus spp., and 30.8% for vancomycin-resistant E. faecium (VRE). There were no very major or major errors noted. Tigecycline exhibited excellent in-vitro activity against Gram-positive cocci, including MRSA, VRE, S. pneumoniae and other Streptococcus spp. isolates in Taiwan. Correlation between MIC values determined using the broth microdilution and Etest methods for these organisms was poor.

KW - Broth microdilution

KW - Etest

KW - Gram-positive cocci

KW - Taiwan

KW - Tigecycline

UR - http://www.scopus.com/inward/record.url?scp=55649083497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55649083497&partnerID=8YFLogxK

U2 - 10.1016/S0924-8579(08)70025-6

DO - 10.1016/S0924-8579(08)70025-6

M3 - Article

C2 - 19013352

AN - SCOPUS:55649083497

VL - 32

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - SUPPL. 3

ER -